Minieye Technology Co., Ltd (stock code: 2431) announced that Joint Company Secretary, Authorised Representative, and Process Agent Ms. Tam Hiu Kwan will resign from her positions, effective February 20, 2026, due to work arrangement adjustments. According to the announcement, Ms. Tam has no disagreement with the board of directors, and there are no matters requiring further attention by Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited, or the company’s shareholders. Following this change, Ms. Chan Yan Lam will assume all three roles effective the same date, while Ms. Luo Xiwen will continue as the other Joint Company Secretary.

Ms. Luo has accumulated more than 12 years of securities affairs and board secretarial experience in listed corporations and joined Minieye Technology in June 2023. She currently oversees securities affairs and investor relations for the group. Ms. Chan, an assistant manager of Company Secretarial Services at Tricor Services Limited, has over six years of corporate secretarial experience. She is a Chartered Secretary, a Chartered Governance Professional, and an associate of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute in the United Kingdom.

In connection with these personnel changes, Minieye Technology has obtained from the Stock Exchange a new waiver from strict compliance with Rules 3.28 and 8.17 of the Listing Rules. This applies from the date of Ms. Chan’s appointment until March 27, 2028. Under the new waiver, Ms. Luo will be assisted by Ms. Chan in fulfilling the duties of Joint Company Secretary. The waiver will be revoked if there are material Listing Rules breaches by Minieye Technology. The company has also stated it will notify the Stock Exchange before the end of the remaining waiver period to reassess Ms. Luo’s experience.

As of the date of the announcement, the board of Minieye Technology comprises four executive directors (Dr. Liu Guoqing, Mr. Yang Guang, Mr. Zhou Xiang, and Mr. Wang Qicheng), two non-executive directors (Mr. Bi Lei and Ms. Liu Yiran), and three independent non-executive directors (Dr. Xiang Yang, Mr. Tan Kaiguo, and Dr. Tan Mingkui).